Celldex Therapeutics sell Wells Fargo & Company
Start price
22.08.23
/
50%
€26.60
Target price
22.08.24
-
Performance (%)
18.80%
End price
23.08.24
€31.60
Summary
This prediction ended on 23.08.24 with a price of €31.60. The prediction closed with a disappointing performance of 18.80%. Wells_Fargo___Compan has a follow-up prediction for Celldex Therapeutics, but this time predicts that Celldex Therapeutics is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Celldex Therapeutics | 3.509% | 3.509% | -7.813% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Wells Fargo & Company. They set an "underweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
In the thread Trading Celldex Therapeutics
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.08.25
20.08.25
€32.67
20.08.26
20.08.26
28.26%
09.01.26
09.01.26
